110 related articles for article (PubMed ID: 9078416)
1. Enzyme replacement therapy.
Roth KS
Clin Pediatr (Phila); 1997 Mar; 36(3):147-8. PubMed ID: 9078416
[No Abstract] [Full Text] [Related]
2. Gaucher and Niemann-Pick diseases--enzymatic diagnosis in dried blood spots on filter paper: retrospective diagnoses in newborn-screening cards.
Chamoles NA; Blanco M; Gaggioli D; Casentini C
Clin Chim Acta; 2002 Mar; 317(1-2):191-7. PubMed ID: 11814475
[TBL] [Abstract][Full Text] [Related]
3. Replacement therapy for inherited enzyme deficiency: liver orthotopic transplantation in Niemann-Pick disease type A.
Daloze P; Delvin EE; Glorieux FH; Corman JL; Bettez P; Toussi T
Am J Med Genet; 1977; 1(2):229-39. PubMed ID: 345809
[TBL] [Abstract][Full Text] [Related]
4. An animal model of human acid sphingomyelinase deficiency (Niemann-Pick disease) and the study of its enzyme replacement (the Japan Society of Human Genetics award lecture).
Kitagawa T
Jinrui Idengaku Zasshi; 1987 Jun; 32(2):55-69. PubMed ID: 2830422
[No Abstract] [Full Text] [Related]
5. [Recent advances in sphingolipidosis research].
Tamai Y; Kojima H
Tanpakushitsu Kakusan Koso; 1990 May; 35(7 Suppl):1291-303. PubMed ID: 1972585
[No Abstract] [Full Text] [Related]
6. Niemann-Pick disease type C or Gaucher's disease type 3? A clinical conundrum.
Pandi S; Chandran V; Deshpande A; Kurien A
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24811560
[TBL] [Abstract][Full Text] [Related]
7. Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane.
Scaggiante B; Pineschi A; Sustersich M; Andolina M; Agosti E; Romeo D
Transplantation; 1987 Jul; 44(1):59-61. PubMed ID: 3037739
[TBL] [Abstract][Full Text] [Related]
8. Toward gene therapy for Niemann-Pick disease (NPD): separation of retrovirally corrected and noncorrected NPD fibroblasts using a novel fluorescent sphingomyelin.
Dinur T; Schuchman EH; Fibach E; Dagan A; Suchi M; Desnick RJ; Gatt S
Hum Gene Ther; 1992 Dec; 3(6):633-9. PubMed ID: 1482703
[TBL] [Abstract][Full Text] [Related]
9. The lipidoses: morphologic changes in the nervous system in Gaucher's disease, GM2 gangliosidoses and Niemann-Pick disease.
Arey JB
Ann Clin Lab Sci; 1975; 5(6):475-88. PubMed ID: 812418
[TBL] [Abstract][Full Text] [Related]
10. Control and therapy of lipid storage diseases: present status and future strategies.
Brady RO
Ala J Med Sci; 1982 Apr; 19(2):161-4. PubMed ID: 7103002
[No Abstract] [Full Text] [Related]
11. Does enzyme replacement therapy enhance brain-derived neurotrophic factor expression in Gaucher disease?
Agilli M; Ekinci S; Fidan G
J Neuroimmunol; 2015 Feb; 279():39. PubMed ID: 25669998
[No Abstract] [Full Text] [Related]
12. Therapy for Gaucher disease: don't stop thinking about tomorrow.
Sidransky E; LaMarca ME; Ginns EI
Mol Genet Metab; 2007 Feb; 90(2):122-5. PubMed ID: 17084653
[TBL] [Abstract][Full Text] [Related]
13. Does enzyme replacement therapy enhance brain-derived neurotrophic factor expression in Gaucher disease?
Vairo F; Sperb-Ludwig F; Wilke M; Michellin-Tirelli K; Netto C; Camargo Neto E; Schwartz IV
J Neuroimmunol; 2015 Jun; 283():63. PubMed ID: 26004158
[No Abstract] [Full Text] [Related]
14. Lessons learned from the development of enzyme therapy for Gaucher disease.
Barranger JA; O'Rourke E
J Inherit Metab Dis; 2001; 24 Suppl 2():89-96; discussion 87-8. PubMed ID: 11758684
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the specific treatments of Gaucher disease].
Meng Y
Zhonghua Nei Ke Za Zhi; 2024 Jul; 63(7):702-711. PubMed ID: 38951097
[TBL] [Abstract][Full Text] [Related]
16. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
Dandana A; Ben Khelifa S; Chahed H; Miled A; Ferchichi S
Pathobiology; 2016; 83(1):13-23. PubMed ID: 26588331
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of biochemical disorders in hereditary enzymopathies in humans and animals].
Rozenfel'd EL
Vopr Med Khim; 1982; 28(3):2-7. PubMed ID: 6125053
[No Abstract] [Full Text] [Related]
18. [Enzyme replacement therapy for Gaucher's disease].
Zimran A; Abrahamov A
Harefuah; 1994 Jun; 126(12):725-9. PubMed ID: 7927019
[No Abstract] [Full Text] [Related]
19. Gaucher and Fabry diseases: from understanding pathophysiology to rational therapies.
Brady RO
Acta Paediatr Suppl; 2003 Dec; 92(443):19-24. PubMed ID: 14989461
[TBL] [Abstract][Full Text] [Related]
20. Treatment of sphingomyelinase deficiency by repeated implantations of amniotic epithelial cells.
Bembi B; Comelli M; Scaggiante B; Pineschi A; Rapelli S; Gornati R; Montorfano G; Berra B; Agosti E; Romeo D
Am J Med Genet; 1992 Nov; 44(4):527-33. PubMed ID: 1442900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
